Skip to content
Study details
Enrolling now

Investigating Wearable Robotic Exoskeleton for Mobility and Cognition in People with MS

Kessler Foundation
NCT IDNCT04855825ClinicalTrials.gov data as of Apr 2026
Target enrollment

10

Study length

about 10 years

Ages

18–75

Locations

1 site in NJ

About this study

This trial is testing whether a wearable robotic exoskeleton can improve mobility, learning, and memory in people with Multiple Sclerosis. It compares traditional gait therapy to using the robotic exoskeleton as part of treatment.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Conventional Gait Therapy
  • 2.Use Robotic Exoskeleton Rehabilitation

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low13%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Body systems

Neurology